首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Simultaneous immobilisation of bioactives during 3D powder printing of bioceramic drug release matrices
【24h】

Simultaneous immobilisation of bioactives during 3D powder printing of bioceramic drug release matrices

机译:在生物陶瓷药物释放基质的3D粉末打印过程中同时固定生物活性物质

获取原文

摘要

The combination of high spatial resolution bioceramic scaffolds and drug delivery systems in one fabrication step by a multicolour 3D printing is beneficial for the reconstruction of bone defects by creating macroporous and microstructured patient specific implants inducing specific biological reactions. In this work we showed that drug localization within low temperature calcium phosphate structures was obtained during 3D powder printing. Furthermore polymer modification with hydroxypropylmethylcellulose (HPMC) or chitosan hydrochloride (ChitHCl) allowed the release profile to be retarded from first to zero order. Vancomycin, heparin and rhBMP-2 showed excellent compatibility with the printing process. Substantial retention of biological activity after printing and release from the bioceramic scaffolds was demonstrated.
机译:通过多色3D打印在一个制造步骤中将高空间分辨率生物陶瓷支架和药物输送系统相结合,可通过产生诱导特定生物学反应的大孔和微结构化患者特定植入物,有利于骨缺损的重建。在这项工作中,我们表明在3D粉末打印过程中获得了低温磷酸钙结构内的药物定位。此外,用羟丙基甲基纤维素(HPMC)或壳聚糖盐酸盐(ChitHCl)进行的聚合物改性使释放特性从一阶延迟到零阶。万古霉素,肝素和rhBMP-2与印刷过程具有极好的相容性。证明了在从生物陶瓷支架上印刷和释放之后生物活性的基本保留。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号